volrustomig
D798EC00001
Phase 3 small_molecule active
Quick answer
volrustomig for Locally Advanced Head and Neck Squamous Cell Carcinoma is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active